ALC250117P75000
- 0.10
- 0.000.00%
Alcon Newsroom
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference
Alcon Labs Recalls Systane Lubricant Eye Drops Over Fungal Contamination
Here's Why Alcon (ALC) Is a Strong Growth Stock
RxSight Cut to Hold at Stifel on Competition Concerns
UBS's Global Equity Focus List: Stocks Within Health Technology
UBS Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $105.57
This Is Why You Should Turn Defensive, Underweight Cyclicals – UBS
Alcon's Late-Stage Pipeline Set To Drive Revenue Growth Next Year -- Market Talk
Alcon Top Pick for 2025 at Needham, Added to Conviction List
Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Alcon (ALC) and Humana (HUM)
Needham Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $108
Alcon Is Maintained at Buy by Needham
Alcon Analyst Ratings
Express News | Alcon AG : Needham Raises Target Price to $108 From $103
Reasons to Retain Alcon Stock in Your Portfolio for Now
Why Alcon (ALC) Is a Top Growth Stock for the Long-Term
UBS Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $107.55
Alcon Inc.'s (VTX:ALC) Intrinsic Value Is Potentially 39% Above Its Share Price
Alcon Inc. (ALC): A Bull Case Theory